Venlafaxine Hydrochloride
- Product NDC
- 42291-898
- 11-digit product format
- 422910898
- Labeler code
- 42291
- Product ID
- 42291-898_488438c1-31da-f4c3-e063-6394a90a9a38
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Venlafaxine Hydrochloride
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- AvKARE
- Application
- ANDA076565
- Marketing category
- ANDA
- Marketing start
- 2013-07-10
- Substance
- VENLAFAXINE HYDROCHLORIDE
- Active strength
- 75 mg/1
- Pharmacologic classes
- Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Venlafaxine Hydrochloride
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| VENLAFAXINE HYDROCHLORIDE | 75 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 7D7RX5A8MO |
| Rxcui | 313581, 313583, 313585 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 42291-898-30 | Venlafaxine Hydrochloride | 30 in 1 BOTTLE | CAPSULE, EXTENDED RELEASE | 30 | | 7 |
| 42291-898-50 | Venlafaxine Hydrochloride | 500 in 1 BOTTLE | CAPSULE, EXTENDED RELEASE | 500 | | 7 |
| 42291-898-90 | Venlafaxine Hydrochloride | 90 in 1 BOTTLE | CAPSULE, EXTENDED RELEASE | 90 | | 7 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| VENLAFAXINE HYDROCHLORIDE | ACTIVE INGREDIENT | 7D7RX5A8MO | VENLAFAXINE HYDROCHLORIDE (VENLAFAXINE HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [AVKARE, INC.] | 2 | |
| VENLAFAXINE | ACTIVE MOIETY | GRZ5RCB1QG | VENLAFAXINE HYDROCHLORIDE (VENLAFAXINE HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [AVKARE, INC.] | 2 | |
| D&C YELLOW NO. 10 | INACTIVE INGREDIENT | 35SW5USQ3G | VENLAFAXINE HYDROCHLORIDE (VENLAFAXINE HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [AVKARE, INC.] | 2 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | VENLAFAXINE HYDROCHLORIDE (VENLAFAXINE HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [AVKARE, INC.] | 2 | |
| ETHYLCELLULOSE (7 MPA.S) | INACTIVE INGREDIENT | H3UP11403C | VENLAFAXINE HYDROCHLORIDE (VENLAFAXINE HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [AVKARE, INC.] | 2 | |
| FD&C YELLOW NO. 6 | INACTIVE INGREDIENT | H77VEI93A8 | VENLAFAXINE HYDROCHLORIDE (VENLAFAXINE HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [AVKARE, INC.] | 2 | |
| FERROSOFERRIC OXIDE | INACTIVE INGREDIENT | XM0M87F357 | VENLAFAXINE HYDROCHLORIDE (VENLAFAXINE HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [AVKARE, INC.] | 2 | |
| GELATIN | INACTIVE INGREDIENT | 2G86QN327L | VENLAFAXINE HYDROCHLORIDE (VENLAFAXINE HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [AVKARE, INC.] | 2 | |
| POLYETHYLENE GLYCOL 400 | INACTIVE INGREDIENT | B697894SGQ | VENLAFAXINE HYDROCHLORIDE (VENLAFAXINE HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [AVKARE, INC.] | 2 | |
| POTASSIUM HYDROXIDE | INACTIVE INGREDIENT | WZH3C48M4T | VENLAFAXINE HYDROCHLORIDE (VENLAFAXINE HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [AVKARE, INC.] | 2 | |
| POVIDONE K30 | INACTIVE INGREDIENT | U725QWY32X | VENLAFAXINE HYDROCHLORIDE (VENLAFAXINE HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [AVKARE, INC.] | 2 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | VENLAFAXINE HYDROCHLORIDE (VENLAFAXINE HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [AVKARE, INC.] | 2 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | VENLAFAXINE HYDROCHLORIDE (VENLAFAXINE HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [AVKARE, INC.] | 2 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | VENLAFAXINE HYDROCHLORIDE (VENLAFAXINE HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [AVKARE, INC.] | 2 | |
| SUCROSE | INACTIVE INGREDIENT | C151H8M554 | VENLAFAXINE HYDROCHLORIDE (VENLAFAXINE HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [AVKARE, INC.] | 2 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | VENLAFAXINE HYDROCHLORIDE (VENLAFAXINE HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [AVKARE, INC.] | 2 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | VENLAFAXINE HYDROCHLORIDE (VENLAFAXINE HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [AVKARE, INC.] | 2 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 42291-898 | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [AVKARE] | 6 | Current NDC, Legacy NDC, 3 package rows | 20240111_7f224c88-9425-9ef0-01bc-dcf3bdafbd89.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 42291-898-30 | 42291089830 | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (42291-898-30) | 2021-06-21 | 0000-00-00 | No | No | Current |
| 42291-898-50 | 42291089850 | 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (42291-898-50) | 2021-06-21 | 0000-00-00 | No | No | Current |
| 42291-898-90 | 42291089890 | 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (42291-898-90) | 2013-07-10 | 0000-00-00 | No | No | Current |